Consistent with OS findings, results from disease-specific survival (DSS) and disease-free interval (DFI) analyses indicated poorer disease-specific survival outcomes in liver cancer patients with high KHDRBS1 expression (Figures 2B, C). The gene discussed is KHDRBS1; the disease is liver cancer.